ProAssurance Co. (NYSE:PRA – Get Free Report) has received a consensus recommendation of “Hold” from the five research firms that are covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $18.67.
PRA has been the subject of a number of research reports. Citizens Jmp cut shares of ProAssurance from an “outperform” rating to a “market perform” rating in a report on Thursday, April 3rd. StockNews.com initiated coverage on shares of ProAssurance in a research report on Wednesday. They set a “hold” rating on the stock. Finally, Citigroup lowered ProAssurance to a “market perform” rating in a research report on Thursday, April 3rd.
Get Our Latest Stock Report on ProAssurance
Institutional Inflows and Outflows
ProAssurance Stock Up 0.4 %
Shares of ProAssurance stock opened at $23.16 on Monday. The stock’s 50-day moving average is $17.87 and its 200 day moving average is $16.43. ProAssurance has a one year low of $10.76 and a one year high of $23.70. The firm has a market cap of $1.18 billion, a price-to-earnings ratio of 27.90 and a beta of -0.09. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.28 and a quick ratio of 0.28.
ProAssurance (NYSE:PRA – Get Free Report) last posted its quarterly earnings results on Monday, February 24th. The insurance provider reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.19. The firm had revenue of $287.52 million for the quarter, compared to analysts’ expectations of $274.56 million. ProAssurance had a return on equity of 2.65% and a net margin of 3.71%. Equities research analysts anticipate that ProAssurance will post 0.8 EPS for the current year.
ProAssurance Company Profile
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Featured Articles
- Five stocks we like better than ProAssurance
- Ride Out The Recession With These Dividend Kings
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- How to Use the MarketBeat Stock Screener
- Are Tariffs Threatening Disney’s Comeback Story?
- Consumer Discretionary Stocks Explained
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.